Whitepapers

Whitepaper: Public Awareness of Clinical Research and the Path to Diversity in Clinical Trials

Part 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects

Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines

Part 8: The Realities of Restart

Part 7: Imagining the Future State of Clinical Research

Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting

Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes

Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research

Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions

Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis

MAGI 2025

May 18, 2025 - May 21, 2025 @ Boston, MA